Prof Christopher Rowe
Director, Adnet
Florey Department of Neuroscience and Mental Health
1251 Scholarly works
27 Projects
HIGHLIGHTS
2024
Journal article
3T sodium-MRI as predictor of neurocognition in nondemented older adults: A cross sectional study
DOI: 10.1093/braincomms/fcae3072024
Research grants (ARC, NHMRC, MRFF)
Imaging and Blood Biomarkers in a New Era for Alzheimer's Disease Treatment
2021
Research grants (ARC, NHMRC, MRFF)
Blood Testing to Predict and Discriminate Dementias
2018
Research Grant
The Australian Dementia Network (Adnet): Bringing Together Australia’s Dementia Stakeholders
2016
Journal article
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease
DOI: 10.1016/j.jalz.2015.12.0132015
Journal article
Phenomenological characterization of memory complaints in preclinical and prodromal alzheimer's disease
DOI: 10.1037/neu00001562013
Journal article
Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests
DOI: 10.3233/JAD-2012-121315
RECENT SCHOLARLY WORKS
2026
Journal article
AI-enhanced Centiloid quantification of amyloid PET images
DOI: 10.1002/alz.711622026
Journal article
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans
DOI: 10.1016/j.tjpad.2025.1004552026
Journal article
Harmonizing neuropsychological test data across prospective studies
DOI: 10.1002/alz.711862026
Journal article
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectories
DOI: 10.1002/alz.711452026
Journal article
When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 Years
DOI: 10.1002/ana.781632026
Journal article
Tau in Alzheimer's disease: Shaping the future patient journey
DOI: 10.1016/j.tjpad.2025.1004472025
Journal article
Biomarkers
DOI: 10.1002/alz70856_1042302025
Journal article
Alzheimer's Imaging Consortium
DOI: 10.1002/alz70862_110840